Novartis AG
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Net Sales by Year
Net Sales (supplemented for financial statements from Form 6-K & 20-F) ($M)
Novartis Net Sales: $54,532M in FY2025, up 8.4% from a year earlier. That is the highest of the 10 years on record here.
Where the FY2025 figure comes from
“|| Net sales to third parties | 9 | 54 532 | 50 317”
Source: Novartis Form 6-K (0001114448-26-000007) ↗
Reported in Form 6-K & Form 20-F (supplementing the blank revenue row in the financial statements).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Net Sales (supplemented for financial statements from Form 6-K & 20-F) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 54,532 | +8.4% | Novartis Form 6-K (0001114448-26-000007) ↗ |
| FY2024 | Dec 31, 2024 | 50,317 | +10.7% | Novartis Form 6-K (0001114448-26-000007) ↗ |
| FY2023 | Dec 31, 2023 | 45,440 | +7.7% | Novartis Form 6-K (0001370368-25-000007) ↗ |
| FY2022 | Dec 31, 2022 | 42,206 | -18.2% | Novartis Form 6-K (0001370368-24-000007) ↗ |
| FY2021 | Dec 31, 2021 | 51,626 | +6.1% | Novartis Form 6-K (0001370368-23-000008) ↗ |
| FY2020 | Dec 31, 2020 | 48,659 | +2.4% | Novartis Form 6-K (0001370368-22-000009) ↗ |
| FY2019 | Dec 31, 2019 | 47,498 | +5.9% | Novartis Form 6-K (0001370368-21-000008) ↗ |
| FY2018 | Dec 31, 2018 | 44,833 | -8.7% | Novartis Form 6-K (0001370368-20-000007) ↗ |
| FY2017 | Dec 31, 2017 | 49,109 | +1.2% | Novartis Form 6-K (0001370368-19-000006) ↗ |
| FY2016 | Dec 31, 2016 | 48,518 | – | Novartis Form 20-F (0001370368-19-000002) ↗ |
Breakdown
What makes up net Sales
- Other Revenues2,142 · FY2025
- Cost of Revenue13,699 · FY2025
- Gross Profit42,975 · FY2025
- Research & Development11,200 · FY2025
- Selling, General & Administrative13,248 · FY2025
- Operating Income17,644 · FY2025
- Equity Method Income-12 · FY2025
- Interest Expense1,144 · FY2025
- Pretax Income16,352 · FY2025
- Income Tax2,385 · FY2025
- Consolidated Net Income13,967 · FY2025
- Minority Interest Income-17 · FY2025
- Net Income13,984 · FY2025
- IFRS Basic EPS (USD/share)7.21 · FY2025
- IFRS Diluted EPS (USD/share)7.15 · FY2025
- Basic Shares (million shares)1,939 · FY2025
- Diluted Shares (million shares)1,955 · FY2025
Cite this data
StockData. (2026). Novartis Net Sales ($M), annual FY2016–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-is-net-sales
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.